Brain implants: What’s standing in the way of pivotal trials, FDA approval
Brain-computer interface startups have shown early safety and functional gains for paralysis, ALS, and vision loss. Pivotal trial endpoints remain unsettled, delaying FDA approval and wider home use.
Why it mattersFDA engagement exists but pivotal trial endpoints remain undefined; investors and founders should expect prolonged approval timelines.
Entities Mentioned
FDA